Cargando…
环孢素联合沙利度胺治疗IPSS低危/中危-1骨髓增生异常综合征远期疗效影响因素分析
OBJECTIVE: To investigate the long-term outcome of cyclosporin A (CsA) combined with thalidomide regime for Chinese patients with IPSS low/intermediate-1 myelodysplastic syndromes (MDS) without del (5q) and the predictive variables which could impact the response to the therapy. METHODS: Seventy-six...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342423/ https://www.ncbi.nlm.nih.gov/pubmed/26632468 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.11.011 |
Ejemplares similares
-
环孢素A联合达那唑±沙利度胺治疗原始细胞不增高骨髓增生异常综合征的疗效及其影响因素分析
Publicado: (2021) -
祛铁治疗对IPSS低危/中危-1骨髓增生异常综合征患者EPO-Stat5信号通路及调节性T细胞表达的影响
Publicado: (2018) -
沙利度胺联合干扰素对Kasumi-1细胞的增殖抑制作用及其机制研究
Publicado: (2015) -
沙利度胺联合环磷酰胺和地塞米松治疗症状性华氏巨球蛋白血症的前瞻性临床研究
Publicado: (2023) -
干扰素α-1b、白细胞介素-2联合沙利度胺方案维持治疗急性髓系白血病的临床观察
Publicado: (2020)